Although the VCAM1–ApoE axis is important for IL-33-stimulated microglial chemotaxis toward Aβ plaques and subsequent Aβ clearance, it is unclear if patients with AD have impaired microglial VCAM1 signaling. Here, IL33 is linked to Alzheimer disease.